Biden administration proposes Medicare and Medicaid coverage for weight-loss drugs like Wegovy for obese Americans, costing up to $35 billion.

I ran for office as unbought and unbossed and I look at this rule wondering who exactly is buying and who is being bossed. On one side are millions of low income, mostly Black and brown women whose bodies have been ridiculed, whose jobs keep them on their feet all day and whose paychecks never stretched to a thousand dollar prescription. On the other side are companies that have already made billions off the Ozempic craze and now want the public programs to guarantee them a steadier stream. Medicare and Medicaid should absolutely be allowed to treat obesity as a real condition, but they should not be turned into automatic funnels for corporate profit without strict rules on marketing, equity, and access. If this 35 billion becomes another example of poor communities being last in line while the well connected get the first appointments, then the policy will have failed the very people it claims to champion. So my answer is not yes or no, it is show me the safeguards and the data before I sign my name.

0